GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Total Payout Yield %

Nuvation Bio (Nuvation Bio) Total Payout Yield % : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Nuvation Bio's current Total Payout Yield % is 0.00%.


Nuvation Bio Total Payout Yield % Historical Data

The historical data trend for Nuvation Bio's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Total Payout Yield % Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Total Payout Yield %
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Payout Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's Total Payout Yield %

For the Biotechnology subindustry, Nuvation Bio's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Total Payout Yield % falls into.



Nuvation Bio Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Nuvation Bio's Total Payout Yield % for the fiscal year that ended in Dec. 2020 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 0 + 0) / 215.93754
=0.00%

Nuvation Bio's annualized Total Payout Yield % for the quarter that ended in Sep. 2021 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 0 + 0) * 4 / 2164.69344
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Nuvation Bio Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.